Premium
Homegrown private equity firm ChrysCapital has returned to invest in a pharmaceutical company that it had helped launch on the bourses less than three years back, two people familiar with the development told VCCircle The PE firm invested around Rs 150 crore ($21 million at current exchange rate) for a 2.6% ......
This is a Premium article. Please subscribe or log in to read the full story!
Here's a selection of our recent premium content.
Already a member? Click here to log in.
